Delveinsight's Extensive Coverage of

ERS 2023 Conference

Brensocatib for Cystic Fibrosis

Brensocatib’s Breakthrough: A Ray of Hope for Cystic Fibrosis and Beyond at ERS International Congress 2023

Insmed Inc.’s creation, Brensocatib, a small oral molecule acting as a reversible inhibitor of dipeptidyl peptidase 1 (DPP1), holds substantial promise for patients with both CF and NCFBE. DPP1 is an enzyme accountable for triggering neutrophil serine proteases (NSPs) in neutrophils, pivotal white blood cells central to infection defense and inflammation regulation.

Read More
Treprostinil palmitil data presented for PH-ILD at ERS 2023

Current treatment for PH-ILD involves the use of drugs like bosentan (an endothelin receptor antagonist), sildenafil (a phosphodiesterase-5 inhibitor), and epoprostenol (a prostacyclin analog) to relieve pulmonary vascular constriction and enhance lung blood flow, ultimately reducing elevated pulmonary artery pressure.

Read More
ERS 2023 Reveals Efzofitimod Data: Pioneering Treatment Hope for SSc-ILD

In a monumental stride toward combating Systemic Sclerosis-Interstitial Lung Disease (SSC-ILD), aTyr Pharma, Inc. unveiled the data related to its first-in-class drug, Efzofitimod, at the European Respiratory Society (ERS) International Congress 2023.

Read More
OXC-201 in IPF: A Closer Look

Oxcia’s OXC-201 is a small molecule inhibitor of OGG1, a potential breakthrough for treating IPF (idiopathic pulmonary fibrosis), other fibrotic conditions, and inflammatory diseases while providing a unique mechanism of action that affects multiple signaling pathways and pathological processes associated with IPF, potentially preventing further lung damage.

Read More
Loading
View All

Case Studies

Reports

acute lung injury market
asthma market
bronchiectasis market
chronic obstructive pulmonary disease copd market
chronic pulmonary hypertension market
chronic thromboembolic pulmonary hypertension cteph market
idiopathic pulmonary fibrosis market
interstitial lung disease market
bronchial neoplasm market
chronic pulmonary infections
eosinophilic asthma market
peripheral arterial disease
tuberculosis market
non cystic fibrosis

NEWSLETTER AND WHITEPAPERS

Acute Respiratory Distress Syndrome

Acute Respiratory Distress Syndrome

The ARDS newsletter provides comprehensive coverage of the treatment landscape. Inside, you'll find information on the currently available medications, treatment protocols, and pharmaceutical companies vying for a competitive edge in the ARDS market. Additionally, the newsletter offers a concise overview of the disease, and a sneak peek at upcoming therapies set to make their mark in the field.

Read More

Need help with project planning?
Consult with our experts today!

contact

Our extensive history and deep knowledge in the field of respiratory health make us an ideal collaborator for addressing your urgent business challenges.

We possess a comprehensive grasp of the respiratory industry's landscape, a detailed insight into market trends, and a keen awareness of marketing intricacies. These strengths can empower you to develop a remarkably effective strategy for future success. Feel free to reach out to us for a conversation about potential collaboration and to explore the extensive value we can bring to your endeavors.

Delivering value with our extensive service portfolio

Considering the rapidly evolving nature of the respiratory therapy field, it is crucial to establish a competitive advantage for your business from the outset. With our extensive range of consulting solutions and market research services, we are ideally positioned to guide you in overcoming challenges and capitalizing on your strengths and opportunities.

Our expertise is geared towards providing actionable insights for gaining a competitive edge and crafting impactful business growth strategies. Join us on this journey to unlock opportunities and avoid potential pitfalls, as we simplify the process of maximizing your return on investment through our expert guidance.

Explore Respiratory
Portfolio Management
Portfolio Management

Partner with us to discover which assets might offer the most potential in the future

Market Assessment
Market Assessment

Our comprehensive 10-year projection offers valuable insights to inform strategic decision-making for a successful market entry.

Competitive Intelligence
Competitive Intelligence

Access our research prowess for timely insights that enhance your business decisions

R&D Analysis
R&D Analysis

We offer support in maneuvering through the challenging drug development process with our insightful intelligence assessments